Financials Synektik Spólka Akcyjna
Equities
SNT
PLSNKTK00019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
138.6 PLN | +3.43% | +2.97% | +61.16% |
Valuation
Fiscal Period: September | 2019 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 122.8 | 516.9 | 1,182 | - | - |
Enterprise Value (EV) 1 | 126.4 | 473.1 | 1,125 | 1,065 | 1,016 |
P/E ratio | 12.7 x | 9.5 x | 12.7 x | 12.2 x | 11 x |
Yield | 2.5% | - | 2.16% | 3.29% | 4.16% |
Capitalization / Revenue | 0.91 x | 1.16 x | 2 x | 1.92 x | 1.76 x |
EV / Revenue | 0.94 x | 1.06 x | 1.9 x | 1.73 x | 1.51 x |
EV / EBITDA | 7.02 x | 4.81 x | 8.4 x | 7.78 x | 6.73 x |
EV / FCF | - | 5.62 x | 21.4 x | 13.8 x | 10.4 x |
FCF Yield | - | 17.8% | 4.67% | 7.24% | 9.58% |
Price to Book | 1.74 x | - | 6.39 x | 4.97 x | 4.13 x |
Nbr of stocks (in thousands) | 8,529 | 8,529 | 8,529 | - | - |
Reference price 2 | 14.40 | 60.60 | 138.6 | 138.6 | 138.6 |
Announcement Date | 08/11/19 | 14/11/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2019 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | 134.8 | 446.9 | 590.9 | 616 | 670.9 |
EBITDA 1 | 18.01 | 98.29 | 133.8 | 136.8 | 151 |
EBIT 1 | 12.78 | 68.79 | 97.5 | 109.9 | 123.4 |
Operating Margin | 9.48% | 15.39% | 16.5% | 17.85% | 18.4% |
Earnings before Tax (EBT) 1 | 12.02 | 68.19 | 90.27 | 95.61 | 106.1 |
Net income 1 | 9.605 | 54.39 | 76.7 | 88.52 | 99.5 |
Net margin | 7.13% | 12.17% | 12.98% | 14.37% | 14.83% |
EPS 2 | 1.130 | 6.380 | 10.90 | 11.34 | 12.64 |
Free Cash Flow 1 | - | 84.18 | 52.5 | 77.06 | 97.41 |
FCF margin | - | 18.84% | 8.88% | 12.51% | 14.52% |
FCF Conversion (EBITDA) | - | 85.64% | 39.24% | 56.32% | 64.49% |
FCF Conversion (Net income) | - | 154.77% | 68.45% | 87.06% | 97.89% |
Dividend per Share 2 | 0.3600 | - | 3.000 | 4.565 | 5.765 |
Announcement Date | 08/11/19 | 14/11/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: September | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | 35.76 | 58.38 | - | 65.66 | 101.7 | 135.7 | 271.3 | 87.7 |
EBITDA 1 | - | - | 12.81 | 29.78 | 10.91 | 24.9 | 32.71 | 53.15 | 25.52 |
EBIT 1 | - | - | 5.578 | 24.63 | 3.183 | 21.08 | 23.95 | 45.37 | 16.61 |
Operating Margin | - | - | 9.55% | - | 4.85% | 20.73% | 17.64% | 16.72% | 18.94% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
Net income | 7.701 | 0.3473 | 2.66 | 19.08 | 4.029 | 13.52 | 17.76 | - | - |
Net margin | - | 0.97% | 4.56% | - | 6.14% | 13.29% | 13.08% | - | - |
EPS | 0.9000 | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - |
Announcement Date | 14/06/22 | 09/08/22 | 22/11/22 | 15/02/23 | 06/06/23 | 08/08/23 | 14/11/23 | 14/02/24 | 11/06/24 |
Balance Sheet Analysis
Fiscal Period: September | 2019 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | 3.62 | - | - | - | - |
Net Cash position 1 | - | 43.8 | 57.6 | 117 | 166 |
Leverage (Debt/EBITDA) | 0.2009 x | - | - | - | - |
Free Cash Flow 1 | - | 84.2 | 52.5 | 77.1 | 97.4 |
ROE (net income / shareholders' equity) | 14.5% | 48.6% | 48% | 42.3% | 38.2% |
ROA (Net income/ Total Assets) | 8.3% | 20.4% | 23% | 21.4% | 20.8% |
Assets 1 | 115.7 | 266.9 | 332.9 | 413.1 | 477.9 |
Book Value Per Share 2 | 8.290 | - | 21.70 | 27.90 | 33.60 |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | 5.7 | 9.97 | 16.9 | 16.9 | 18 |
Capex / Sales | 4.23% | 2.23% | 2.86% | 2.75% | 2.68% |
Announcement Date | 08/11/19 | 14/11/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+61.16% | 283M | |
+3.77% | 213B | |
+8.83% | 188B | |
+31.94% | 157B | |
+33.19% | 113B | |
+5.25% | 64.85B | |
+22.41% | 55.17B | |
+1.34% | 49.1B | |
-5.92% | 38.83B | |
+1.94% | 35.6B |
- Stock Market
- Equities
- SNT Stock
- Financials Synektik Spólka Akcyjna